Eudaimonia Asset Management »

Amneal Pharmaceuticals shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 426k 12.60
2023-09-30 $972k 230k 4.22
2021-03-31 $1.7M 260k 6.73

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Assenagon Asset Management
Neuberger Berman Group
Millennium Management
Nuveen
Goldman Sachs Group
Nantahala Capital Management
BlackBarn Capital Partners

View all funds holding Amneal Pharmaceuticals